About Novo Biosciences
Novo Biosciences is a company based in Bar Harbor (United States) founded in 2013 by Kevin Strange and Voot Yin.. Novo Biosciences has raised $4.08 million across 2 funding rounds. The company has 2 employees as of December 31, 2021. Novo Biosciences operates in a competitive market with competitors including Ilya Pharma, Rani Therapeutics, QBiotics, MediWound and Resolution Therapeutics, among others.
- Headquarter Bar Harbor, United States
- Employees 2 as on 31 Dec, 2021
- Founders Kevin Strange, Voot Yin
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.08 M (USD)
in 2 rounds
-
Latest Funding Round
$4 M (USD), Series A
Jun 09, 2020
-
Investors
-
Employee Count
2
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Novo Biosciences
Novo Biosciences has successfully raised a total of $4.08M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $4.0M
-
First Round
First Round
(16 Jul 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Series A - Novo Biosciences | Valuation |
investors |
|
| Jul, 2015 | Amount | Seed - Novo Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Novo Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Novo Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novo Biosciences Comparisons
Competitors of Novo Biosciences
Novo Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, Rani Therapeutics, QBiotics, MediWound and Resolution Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Technology for oral delivery of large drug molecules is developed.
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| domain | founded_year | HQ Location |
Noninvasive devices and biologics for wound healing are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Novo Biosciences
When was Novo Biosciences founded?
Novo Biosciences was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Where is Novo Biosciences located?
Novo Biosciences is headquartered in Bar Harbor, United States. It is registered at Bar Harbor, Maine, United States.
Who is the current CEO of Novo Biosciences?
Kevin Strange is the current CEO of Novo Biosciences. They have also founded this company.
Is Novo Biosciences a funded company?
Novo Biosciences is a funded company, having raised a total of $4.08M across 2 funding rounds to date. The company's 1st funding round was a Seed of $75K, raised on Jul 16, 2015.
How many employees does Novo Biosciences have?
As of Dec 31, 2021, the latest employee count at Novo Biosciences is 2.
What does Novo Biosciences do?
Novo Biosciences was founded in 2013 and is based in Bar Harbor, United States. As a regenerative medicine company, small molecule therapies are developed by it to stimulate innate healing abilities in humans and animals. The lead compound, ZF143, is in the preclinical stage and targets applications such as wound healing acceleration and tissue or organ repair and regeneration.
Who are the top competitors of Novo Biosciences?
Novo Biosciences's top competitors include Ilya Pharma, Rani Therapeutics and SanuWave.